Twist Bioscience (TWST) Operating Leases: 2019-2025
Historic Operating Leases for Twist Bioscience (TWST) over the last 6 years, with Sep 2025 value amounting to $75.6 million.
- Twist Bioscience's Operating Leases rose 7.62% to $75.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.6 million, marking a year-over-year increase of 7.62%. This contributed to the annual value of $75.6 million for FY2025, which is 7.62% up from last year.
- Per Twist Bioscience's latest filing, its Operating Leases stood at $75.6 million for Q3 2025, which was down 3.30% from $78.2 million recorded in Q2 2025.
- Twist Bioscience's Operating Leases' 5-year high stood at $94.0 million during Q4 2022, with a 5-year trough of $22.2 million in Q1 2021.
- Over the past 3 years, Twist Bioscience's median Operating Leases value was $82.6 million (recorded in 2024), while the average stood at $83.5 million.
- As far as peak fluctuations go, Twist Bioscience's Operating Leases crashed by 34.99% in 2021, and later spiked by 258.13% in 2022.
- Over the past 5 years, Twist Bioscience's Operating Leases (Quarterly) stood at $60.3 million in 2021, then skyrocketed by 55.88% to $94.0 million in 2022, then decreased by 2.23% to $91.9 million in 2023, then declined by 10.08% to $82.6 million in 2024, then grew by 7.62% to $75.6 million in 2025.
- Its Operating Leases stands at $75.6 million for Q3 2025, versus $78.2 million for Q2 2025 and $80.3 million for Q1 2025.